Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients
NCT05901025 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2023-06-13
Summary
The goal of this clinical trial is to learn about the mutation spectrum of homologous recombination repair pathway genes and its instructive significance in the treatment of Chinese breast cancer patients.
Conditions
Sponsors & Collaborators
-
Shanghai Jiao Tong University School of Medicine
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-05
- Primary Completion
- 2028-06-30
- Completion
- 2033-06-30
More Related Trials
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer
NCT04970264 ·Status: UNKNOWN
-
Genetic Alteration After Systemic Treatment in Breast Cancer
NCT02591966 ·Status: UNKNOWN
-
Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients
NCT07052734 ·Status: COMPLETED
-
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 ·Status: UNKNOWN
-
Familial Breast Cancer in China
NCT06833216 ·Status: NOT_YET_RECRUITING
-
Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer
NCT05466786 ·Status: RECRUITING
-
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer
NCT00323908 ·Status: COMPLETED
-
Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer
NCT01199393 ·Status: COMPLETED
-
Breast Cancer Molecular Analysis Protocol
NCT01855503 ·Status: COMPLETED
-
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT05079074 ·Status: COMPLETED
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer
NCT05858242 ·Status: RECRUITING
-
Assessment of Candidate Protein Expression in Breast Cancer Specimens
NCT00918892 ·Status: COMPLETED
-
Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR
NCT03947736 ·Status: UNKNOWN
-
Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography
NCT01124019 ·Status: COMPLETED
-
Characteristics and Treatment Trends of Young Breast Cancer in China
NCT05068115 ·Status: UNKNOWN
-
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer
NCT02530008 ·Status: ACTIVE_NOT_RECRUITING
-
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
NCT05427617 ·Status: COMPLETED
-
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034 ·Status: UNKNOWN
-
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
NCT06876610 ·Status: RECRUITING
-
The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients
NCT02669745 ·Status: COMPLETED
-
Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 ·Status: UNKNOWN
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer
NCT01716247 ·Status: COMPLETED ·Phase: NA